# FDA 483 - Natalia E. Castillo Almeida, MD - September 11, 2025

Source: https://www.globalkeysolutions.net/records/483/natalia-e-castillo-almeida-md/dfe6427f-bf88-4348-a136-81b573730527

> FDA 483 for Natalia E. Castillo Almeida, MD on September 11, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Natalia E. Castillo Almeida, MD
- Inspection Date: 2025-09-11
- Product Type: drugs
- Office Name: Kansas City District Office
- Summary: The FDA inspected the University of Nebraska Medical Center in Omaha, NE, from September 5-11, 2025, focusing on clinical investigation practices. The inspection revealed a significant failure by the Principal Investigator to report non-serious adverse events to the study sponsor as required by the protocol. This indicates a serious lapse in adherence to clinical trial reporting requirements.

## Related Officers

- [Melissa S. Mcguinness](https://www.globalkeysolutions.net/people/melissa-s-mcguinness/5a7054ba-be7b-488a-a244-294b85c33d0b)
- [Veronica L. Bush](https://www.globalkeysolutions.net/people/veronica-l-bush/3582dd62-2cdf-4d1d-a78b-305c908ef9d5)

Company: https://www.globalkeysolutions.net/companies/natalia-e-castillo-almeida-md/8a5e8078-1adb-428f-ae51-561fbc13915a

Office: https://www.globalkeysolutions.net/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79